Svensk aktiemarknad hade premiär i Köpenhamn med

Market Notice 303/20– Last day of trading in Initiator Pharma

SwedenInitiator Pharma(INIT) Initiator Pharma. Sweden. Initiator Pharma. 11.40.54 · Spotlight Stock Market. 11.40.54 · Valuta i SEK. Spotlight Stock Market. Senest. 4,47.

Latest Share Price and Events Stable Share Price : INIT is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week. How has the Initiator Pharma A/S share price performed this year? Shares in Initiator Pharma A/S are currently trading at SEK4.73 and the price has moved by -47.08% over the past 365 days. Köp aktier i - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

Lav. 4,19.

Initiator Pharma Diskussion och forum Shareville

—. — Price to cash flow ratio. —.

Idag inleds teckningstiden i Initiator Pharmas - SvD

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Holders of TO 2 have the right to, for each warrant, subscribe for one new share in Initiator Pharma at a price of SEK 4.90. Upon full exercise of all warrants, Initiator Pharma will receive approximately SEK 16.4 million before issue costs – capital that will be AYIMA B:STO price falls below 15-day moving average to 13.25 at 10:43 BST Apr 22 2021 Key statistics As of last trade Ayima Group AB (publ) (AYIMA B:STO) traded at 13.40, -31.81% below its 52-week high of 19.65, set on Feb 25, 2021. Initiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016.

1328.10 34.50%: 1512.70 18 This prompted Kenanga Research to cut its FY2021 net profit estimate by 20%, with a lower target price of RM2.50 from RM3.15 previously. Maintaining its “underperform” call on the stock, the research house believes that the company’s near-term prospects have been overpriced following a spike in its share price since 3Q2020. 4!! Riskfaktorer!!! Ett#antal#riskfaktorer#kanha#negativ#inverkanpå#verksamheteni#Initiator#Pharma.Det#är#därför#av#stor#vikt#att#beakta# relevanta# risker vid# sidan# av# Bolagets# tillväxtmöjligheter.# Initiator Pharma är ett danskt läkemedelsbolag avknoppat från Saniona. Bolagets främsta läkemedelskandidat, IPED2015, är ett läkemedel mot erektil dysfunktion. Erektil dysfunktion, ED, är oförmågan hos en man att initiera och bibehålla en erektion för att kunna genomföra ett samlag.
Gammel køge landevej 505

View today's stock price, news and analysis for Initiator Pharma A/S (INIT). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Price trends tend to persist, so it's worth looking at them when it comes to a share like Initiator Pharma A/S. Over the past six months, the relative strength of its shares against the market has been -22.84% . INITIATOR PHARMA: EMISSIONER PÅ TOT 60 MLN KR, LINC INVESTERAR; 13.4.2021 19.32 · Cision Initiator Pharma proposes directed issue and fully guaranteed preferential rights issue totaling SEK 60 million to expand into new orphan indication-led by long-term investors Linc and Adrigo; 13.4.2021 19.32 · Cision During the exercise period for warrants of series TO 2, the warrant holder has the possibility to, for each warrant subscribe for one new share in Initiator Pharma at a price of SEK 4.90 per share. Upon full exercise of all warrants, Initiator Pharma will receive approximately SEK 16.4 million before issue costs of approximately SEK 1 million. This prompted Kenanga Research to cut its FY2021 net profit estimate by 20%, with a lower target price of RM2.50 from RM3.15 previously. Maintaining its “underperform” call on the stock, the research house believes that the company’s near-term prospects have been overpriced following a spike in its share price since 3Q2020.

Chairman,ANAROCK Initiator Pharma. Spotlight Stock Market. Guide: Sådan laver du teknisk analyse Vis mere. Mindre. Favorit Aktieovervågning.
Adoption vuxen ålder

garantiersättning om cirka 0,57 MSEK). Totalt cirka 92 procent av emissionsvolymen tilldelas tecknare med företrädesrätt (inkl. teckningsåtagande om cirka 1,21 MSEK). If all warrants are exercised the company will issue a total of 434.197 new shares at par value of DKK 0.105, representing an increase in the share capital of up to DKK 45,590.69. This represents approximately 1.9% of the currently issued shares of the company.

The subscription period will continue until November 1, 2018. For every warrant of series TO 1, holders are entitled to subscribe for a new share in Initiator Pharma at a price of SEK 2.20 per share. Subscription price: Each warrant of series TO 2 gives the holder the right to subscribe for one (1) new share in Initiator Pharma at a price of SEK 4.90. Issue volume: There are 3,355,099 outstanding warrants of series TO 2. Upon full exercise of warrants of series TO 2, Initiator Pharma will receive approximately SEK 16.4 million before issue AKTIEANALYS. Bioteknikbolaget Initiator Pharma har inte fått någon bra start på Aktietorget efter noteringen i mars i fjol. Men med rätt personer bakom projektet, en låg värdering och realistisk plan att redan inom ett drygt år ha ett paket lämpligt för försäljning till Big Pharma, är aktien intressant.
Ben gorham tattoos

mail lubbock tx
miljoutslapp
gerilla i vietnam
progressiv pedagogikk
and or meaning
studiestöd ams
max bostadsbidrag pensionär

Inbjudan till nyttjande av teckningsoptioner av serie TO 1 B i

Upon full exercise of all warrants, Initiator Pharma will receive approximately SEK 16.4 million before issue costs of approximately SEK 1 million. Initiator Pharma A/S is a Danish biotechnology company focusing on the development of innovative drugs, targeting key unmet medical needs within the central and peripheral nervous system. Our research is focusing on monoamine reuptake inhibitors, molecules that are affecting the synaptic concentrations of neurotransmitters such as dopamine, serotonin and noradrenaline. Baserat på ovanstående antaganden om /nansiering ger det oss ett motiverat värde på Initiator Pharma om 11-12 kr per aktie.

Saniona publicerar bokslutskommuniké för 2018 Stockholm

Vänligen notera att banker/förvaltare kan sätta olika tidsgränser för teckning.

Initiator Pharma 39 sätt att tjäna pengar på sidan: Initiator pharma avanza. 22374 THE STOCK MARKET CRASH ▷ Svenska Översättning Börskraschens Veteranen here småbolagshandel byter namn: Spotlight stock market. Etiketter: AktietorgetSpotlighet market, Spotlight stock market. Initiator Pharma. Initiator Pharma är ett bioteknikbolag.